Department of Cardiovascular Surgery, Dijon Hospital, Dijon, France.
Ann Thorac Surg. 2010 Jun;89(6):1912-7. doi: 10.1016/j.athoracsur.2010.03.015.
A bloodless field is important for visualizing relevant anatomical structures and facilitating construction of high-quality coronary anastomoses during off-pump coronary artery bypass graft surgery (OPCABG). Currently employed devices can damage target arteries as well as myocardium and are not uniformly effective, especially with diseased arteries.
LeGoo (Pluromed, Woburn, MA) is a thermosensitive polymer that is a viscous liquid at room temperatures and changes into a firm occlusive plug instantaneously when exposed to body temperatures. The polymer is nontoxic and neither metabolized nor absorbed. It dissolves spontaneously or can be dissolved at will by cooling. LeGoo was instilled through the arteriotomy of 99 coronaries in 50 patients during construction of OPCABG anastomoses.
LeGoo formed an occlusive endoluminal plug instantaneously and blocked blood flow into the surgical field. In 89 vessels with available information, the quality of bloodless field was satisfactory, without need for substantial use of blood removal systems or application of another device in 81 vessels (91%). Resort to other means was prompted by serious arrhythmia (1 case) epicardial bleeding (1 vessel), bleeding from collateral branches (3 vessels), and shortcomings in design of the injecting catheter (3 vessels) that has been corrected. Intraoperative and perioperative profiles of these patients were similar to those reported from other OPCABG series. Abnormal bleeding, coagulopathy, metabolic derangements, and evidence of LeGoo embolization were not observed.
In this first large-scale human experience, LeGoo had been an atraumatic, safe, and effective temporary coronary artery occluder. It produced a bloodless field during OPCABG in 91% of target vessels. Improvements on these results with further experience is anticipated.
在非体外循环冠状动脉旁路移植术(OPCABG)中,无血手术野对于可视化相关解剖结构和构建高质量的冠状动脉吻合至关重要。目前使用的器械可能会损伤靶动脉和心肌,并且效果并不均匀,尤其是在病变的动脉中。
LeGoo(Pluromed,Woburn,MA)是一种热敏聚合物,在室温下呈粘性液体状态,当暴露于体温时会立即变成坚固的闭塞塞。聚合物无毒,既不代谢也不吸收。它会自行溶解,也可以通过冷却随意溶解。在 50 名患者的 OPCABG 吻合术中,通过动脉切开术将 LeGoo 注入 99 条冠状动脉。
LeGoo 立即形成一个闭塞的腔内塞,阻断了血流进入手术野。在 89 条有可用信息的血管中,无血手术野的质量令人满意,在 81 条血管(91%)中无需大量使用血液清除系统或应用另一种器械。在 1 例严重心律失常、1 例心外膜出血、3 例侧支分支出血和 3 例注射导管设计缺陷的情况下,需要采取其他措施。这些患者的术中及围术期情况与其他 OPCABG 系列报道相似。未观察到异常出血、凝血功能障碍、代谢紊乱和 LeGoo 栓塞的证据。
在这项首次大规模人体试验中,LeGoo 是一种无创伤、安全、有效的临时冠状动脉闭塞器。它在 91%的靶血管中产生了无血手术野。随着经验的进一步积累,预计会有更好的结果。